These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38707050)

  • 1. The Management of Xylazine Overdose With Naloxone.
    Morris J; Hoang D
    Cureus; 2024 Apr; 16(4):e57638. PubMed ID: 38707050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Illicit Drugs May Contain Veterinary Tranquilizer.
    Aschenbrenner DS
    Am J Nurs; 2023 Mar; 123(3):20-21. PubMed ID: 36815816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xylazine, a Veterinary Tranquilizer, Detected in 42 Accidental Fentanyl Intoxication Deaths.
    Nunez J; DeJoseph ME; Gill JR
    Am J Forensic Med Pathol; 2021 Mar; 42(1):9-11. PubMed ID: 33031124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Appearance of Xylazine in the United States as a Fentanyl Adulterant.
    Leconte CE; Sethi R
    Prim Care Companion CNS Disord; 2023 Oct; 25(6):. PubMed ID: 37923548
    [No Abstract]   [Full Text] [Related]  

  • 5. Qualitative and quantitative characteristics of xylazine-associated deaths detected using a post-mortem toxicology testing program.
    Vohra V; Stroh-Steiner GK; Jones P
    Clin Toxicol (Phila); 2023 Dec; 61(12):1040-1046. PubMed ID: 38088581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid overdoses involving xylazine in emergency department patients: a multicenter study.
    Love JS; Levine M; Aldy K; Brent J; Krotulski AJ; Logan BK; Vargas-Torres C; Walton SE; Amaducci A; Calello D; Hendrickson R; Hughes A; Kurt A; Judge B; Pizon A; Schwarz E; Shulman J; Wiegan T; Wax P; Manini AF
    Clin Toxicol (Phila); 2023 Mar; 61(3):173-180. PubMed ID: 37014353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xylazine in the Opioid Epidemic: A Systematic Review of Case Reports and Clinical Implications.
    Ayub S; Parnia S; Poddar K; Bachu AK; Sullivan A; Khan AM; Ahmed S; Jain L
    Cureus; 2023 Mar; 15(3):e36864. PubMed ID: 37009344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National Institute on Drug Abuse Clinical Trials Network Meeting Report: Managing Patients Exposed to Xylazine-Adulterated Opioids in Emergency, Hospital and Addiction Care Settings.
    Perrone J; Haroz R; D'Orazio J; Gianotti G; Love J; Salzman M; Lowenstein M; Thakrar A; Klipp S; Rae L; Reed MK; Sisco E; Wightman R; Nelson LS
    Ann Emerg Med; 2024 Jul; 84(1):20-28. PubMed ID: 38493376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case series of accidental xylazine intoxication in humans; Is there a role of naloxone as an antidote?
    Choon LK; Khiruddin AI; Annuar WMWM; Shamsuddin SR
    Turk J Emerg Med; 2023; 23(2):119-122. PubMed ID: 37169031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xylazine Complicating Opioid Ingestions in Young Children.
    Deutsch SA; De Jong AR
    Pediatrics; 2023 Jan; 151(1):. PubMed ID: 36550066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xylazine spreads across the US: A growing component of the increasingly synthetic and polysubstance overdose crisis.
    Friedman J; Montero F; Bourgois P; Wahbi R; Dye D; Goodman-Meza D; Shover C
    Drug Alcohol Depend; 2022 Apr; 233():109380. PubMed ID: 35247724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology and toxicology of xylazine: quid novum?
    Malaca S; Pesaresi M; Kapoor A; Berretta P; Busardò FP; Pirani F
    Eur Rev Med Pharmacol Sci; 2023 Aug; 27(15):7337-7345. PubMed ID: 37606142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xylazine: A Drug Adulterant of Clinical Concern.
    Edinoff AN; Sall S; Upshaw WC; Spillers NJ; Vincik LY; De Witt AS; Murnane KS; Kaye AM; Kaye AD
    Curr Pain Headache Rep; 2024 May; 28(5):417-426. PubMed ID: 38507135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xylazine: The Drug Taking the World By Storm: What You Need to Know.
    Mumba MN; Tice J; Brown W
    J Psychosoc Nurs Ment Health Serv; 2023 Dec; 61(12):7-10. PubMed ID: 38051681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing the harm of opioid overdose with the safe use of naloxone : a pharmacologic review.
    Kim HK; Nelson LS
    Expert Opin Drug Saf; 2015 Jul; 14(7):1137-46. PubMed ID: 25865597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xylazine induced central antinociception mediated by endogenous opioids and μ-opioid receptor, but not δ-or κ-opioid receptors.
    Romero TR; Pacheco Dda F; Duarte ID
    Brain Res; 2013 Apr; 1506():58-63. PubMed ID: 23485547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xylazine potentiates the lethal but not the rewarding effects of fentanyl in mice.
    Acosta-Mares P; Violante-Soria V; Browne T; Cruz SL
    Drug Alcohol Depend; 2023 Dec; 253():110993. PubMed ID: 37883846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic toxicity from subcutaneous brimonidine injection successfully treated with naloxone.
    Tobarran N; Kershner E; Chambers A; Cumpston KL; Wills BK
    Am J Emerg Med; 2022 Sep; 59():218.e5-218.e6. PubMed ID: 35835657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition and Treatment of Wounds in Persons Using Xylazine: A Case Report From New Haven, Connecticut.
    Dowton A; Doernberg M; Heiman E; Barelli P; Golden M; Wang H; Leventhal J; Morford KL; Sue KL
    J Addict Med; 2023 Nov-Dec 01; 17(6):739-741. PubMed ID: 37934550
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.